Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 162

1.

A comprehensive review of behavioral interventions for weight management in schizophrenia.

Loh C, Meyer JM, Leckband SG.

Ann Clin Psychiatry. 2006 Jan-Mar;18(1):23-31. Review.

PMID:
16517450
2.

Behavioral therapy for weight loss in patients with schizophrenia.

Ganguli R.

J Clin Psychiatry. 2007;68 Suppl 4:19-25. Review.

3.

Reversal of antipsychotic-associated weight gain.

O'Keefe CD, Noordsy DL, Liss TB, Weiss H.

J Clin Psychiatry. 2003 Aug;64(8):907-12.

PMID:
12927005
4.

Schizophrenia and weight management: a systematic review of interventions to control weight.

Faulkner G, Soundy AA, Lloyd K.

Acta Psychiatr Scand. 2003 Nov;108(5):324-32. Review.

PMID:
14531752
5.

Behavioral treatment of obesity in patients taking antipsychotic medications.

Kalarchian MA, Marcus MD, Levine MD, Haas GL, Greeno CG, Weissfeld LA, Qin L.

J Clin Psychiatry. 2005 Aug;66(8):1058-63.

PMID:
16086623
6.

Antipsychotic induced weight gain in schizophrenia:mechanisms and management.

Rege S.

Aust N Z J Psychiatry. 2008 May;42(5):369-81. doi: 10.1080/00048670801961123. Review.

PMID:
18473255
8.

The role of lifestyle interventions and weight management in schizophrenia.

Bushe C, Haddad P, Peveler R, Pendlebury J.

J Psychopharmacol. 2005 Nov;19(6 Suppl):28-35. Review.

PMID:
16280335
9.

[Non-pharmacological interventions for weight gain in patients with schizophrenia taking antipsychotics].

Attux C, Martini LC, Reis AF, Bressan RA.

Arq Bras Endocrinol Metabol. 2009 Jun;53(4):391-8. Review. Portuguese.

10.

Attenuation of antipsychotic-induced weight gain with early behavioral intervention in drug-naive first-episode psychosis patients: A randomized controlled trial.

Alvarez-Jiménez M, González-Blanch C, Vázquez-Barquero JL, Pérez-Iglesias R, Martínez-García O, Pérez-Pardal T, Ramírez-Bonilla ML, Crespo-Facorro B.

J Clin Psychiatry. 2006 Aug;67(8):1253-60.

PMID:
16965204
11.
12.

Behavioral interventions for obesity.

Berkel LA, Poston WS, Reeves RS, Foreyt JP.

J Am Diet Assoc. 2005 May;105(5 Suppl 1):S35-43. Review.

PMID:
15867894
13.

Management of atypical antipsychotic drug-induced weight gain: focus on metformin.

Miller LJ.

Pharmacotherapy. 2009 Jun;29(6):725-35. doi: 10.1592/phco.29.6.725. Review.

PMID:
19476423
14.

Weight loss and long-term follow-up of severely obese individuals treated with an intense behavioral program.

Anderson JW, Grant L, Gotthelf L, Stifler LT.

Int J Obes (Lond). 2007 Mar;31(3):488-93. Epub 2006 Jul 4. Erratum in: Int J Obes (Lond). 2007 Mar;31(3):565.

PMID:
16819530
15.

[Therapeutic options for weight management in schizophrenic patients treated with atypical antipsychotics].

Cordes J, Sinha-Röder A, Kahl KG, Malevani J, Thuenker J, Lange-Asschenfeldt C, Hauner H, Agelink MW, Klimke A.

Fortschr Neurol Psychiatr. 2008 Dec;76(12):703-14. doi: 10.1055/s-2008-1038279. Epub 2008 Oct 15. Review. German.

PMID:
18924059
16.

Efficacy of behavioural interventions in managing atypical antipsychotic weight gain.

Gabriele JM, Dubbert PM, Reeves RR.

Obes Rev. 2009 Jul;10(4):442-55. doi: 10.1111/j.1467-789X.2009.00570.x. Epub 2009 Mar 6. Review. Erratum in: Obes Rev. 2009 Jul;10(4):493.

PMID:
19389059
17.

Schizophrenia, obesity, and antipsychotic medications: what can we do?

Citrome L, Vreeland B.

Postgrad Med. 2008 Jul;120(2):18-33. doi: 10.3810/pgm.2008.07.1786. Review.

PMID:
18654065
18.

A randomized controlled trial of two weight-reducing short-term group treatment programs for obesity with an 18-month follow-up.

Stahre L, Tärnell B, Håkanson CE, Hällström T.

Int J Behav Med. 2007;14(1):48-55.

PMID:
17511533
19.

Non-pharmacological management of antipsychotic-induced weight gain: systematic review and meta-analysis of randomised controlled trials.

Alvarez-Jiménez M, Hetrick SE, González-Blanch C, Gleeson JF, McGorry PD.

Br J Psychiatry. 2008 Aug;193(2):101-7. doi: 10.1192/bjp.bp.107.042853. Review.

20.

Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.

Lewis SW, Davies L, Jones PB, Barnes TR, Murray RM, Kerwin R, Taylor D, Hayhurst KP, Markwick A, Lloyd H, Dunn G.

Health Technol Assess. 2006 May;10(17):iii-iv, ix-xi, 1-165.

Supplemental Content

Support Center